We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cell Block Technique Detects Low Frequency Abnormal Cells

By LabMedica International staff writers
Posted on 15 Jan 2013
Different cell block techniques have been compared for the detection of low frequency abnormal cells and representative sampling with simple sedimentation.

Automated cell block systems rapidly create paraffin-embedded cell blocks by using vacuum filtration to deposit a layer of cells on a filter and infiltrate those cells with reagents and paraffin.

Scientists at Hologic Inc (Marlborough, MA, USA) compared three cell block systems using a novel tracer-cell model consisting of epidermoid carcinoma (CaSki) cells (American Type Culture Collection; Manassas, VA, USA). More...
The cells were prestained in solution with hematoxylin and serially diluted in a background of pooled clinical serous effusion specimens and quantified using a hemocytometer. Ten replicates diluted cells were processed using each cell block method, and the resulting blocks were cut to produce two slides from each block. The slides were deparaffinized, counterstained with eosin, cover-slipped, and screened for the presence of tracer cells.

Tracer cells were identified on the initial slides for 20 of 40 simple sedimentation cell blocks, 21 of 40 in Richard-Allan HistoGel cell blocks (Thermo Scientific, Waltham, MA, USA), and 25 of 40 Hologic's Cellient cell blocks. All three methods showed representative sampling in 100% of the blocks made from the 100 tracer/mL specimen. With blocks made from the 10 tracer/mL specimen, simple sedimentation, HistoGel, and Cellient showed 90.0%, 80.0%, and 100% representative sampling, respectively. Representative sampling at the 1 tracer/mL dilution was 10.0% for simple sedimentation and 30% for HistoGel and Cellient. At the 0.1 tracer/mL dilution, only Cellient showed representative sampling.

The authors concluded that the detection of low concentration CaSki tracer cells was greater in Cellient cell blocks compared with simple sedimentation and HistoGel cell blocks. The Cellient cell blocks required the least amount of recutting, and demonstrated representative sampling at the lowest tracer cell concentration. A benefit of the Cellient system is that it concentrates cellular material on a membrane filter, resulting in a cell block with all the cells at or near the face of the block. The study was published on January 3, 2013, in the journal Pathology and Laboratory Medicine International.

Related Links:

Hologic Inc.
American Type Culture Collection
Thermo Scientific



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.